References

1. Du M, Yan X, Tong JF, Zhao J, Zhu MJ (2010) Maternal obesity, inflammation, and fetal skeletal muscle development. View
2. Zhu MJ, Ford SP, Means WJ, Hess BW, Nathanielsz PW, et al. (2006) Maternal nutrient restriction affects properties of skeletal muscle in offspring. View
3. Lowell BB, Shulman GI (2005) Mitochondrial dysfunction and type 2 diabetes. View
4. Oak SA, Tran C, Pan G, Thamotharan M, Devaskar SU (2006) Perturbed skeletal muscle insulin signaling in the adult female intrauterine growthrestricted rat. View
5. Floyd ZE, Trausch-Azar JS, Reinstein E, Ciechanover A, Schwartz AL (2001) The nuclear ubiquitin-proteasome system degrades MyoD. View
6. Blomen VA, Boonstra J (2007) Cell fate determination during G1 phase progression. View
7. Saab R, Bills JL, Miceli AP, Anderson CM, Khoury JD, Fry DW, et al. (2006) Pharmacologis inhibition of cyclin-dependent-kinase 4/6 activity arrests proliferation in myoblasts and rhabdosarcoma-derived cells. Mol Cancer Ther 5: 1299-1308. View
8. De Santa F, Albini S, Mezzaroma E, Baron L, Felsani A, et al. (2007) pRb-dependent cyclin D3 protein stabilization is required for myogenic differentiation. View
9. Besson A, Dowdy SF, Roberts JM (2008) CDK inhibitors: cell cycle regulators and beyond. View
10. Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, et al. (2002) E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. View
11. De Falco M, De Luca A (2006) Involvement of cdks and cyclins in muscle differentiation. View
12. Le Grand F, Rudnicki MA (2007) Skeletal muscle satellite cells and adult myogenesis. View
13. Grzelkowska-Kowalczyk K, Wieteska-Skrzeczyńska W, Grabiec K, Tokarska J (2013) High glucose-mediated alterations of mechanisms important in myogenesis of mouse C2C12 myoblasts. View
14. Grzelkowska-Kowalczyk K, Wieteska W (2006) Mouse C2C12 myoblasts exposed to high glucose and high insulin as a cellular model of insulin resistance in skeletal muscle. Med Wet 62: 690-695.
15. Grzelkowska-Kowalczyk K1, Wieteska W (2005) The impairment of IGF-Istimulated protein synthesis and activation of protein kinase B, p70(S6k), MAP kinase, and p90(rsk) in mouse C2C12 myogenic cells exposed to high glucose and high insulin. View
16. Yaffe D, Saxel O (1977) Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. View
17. Grabiec K, Gajewska M, Milewska M, BÅ‚aszczyk M, Grzelkowska- Kowalczyk K (2014) The influence of high glucose and high insulin on mechanisms controlling cell cycle progression and arrest in mouse C2C12 myoblasts: the comparison with IGF-I effect. View
18. Fujita N, Furukawa Y, Du J, Itabashi N, Fujisawa G, et al. (2002) Hyperglycemia enhances VSMC proliferation with NF-kappaB activation by angiotensin II and E2F-1 augmentation by growth factors. View
19. Nedachi T, Kadotani A, Ariga M, Katagiri H, Kanzaki M (2008) Ambient glucose levels qualify the potency of insulin myogenic actions by regulating SIRT1 and FoxO3a in C2C12 myocytes. View
20. Wei Q, Paterson BM (2001) Regulation of MyoD function in the dividing myoblast. View
21. Huh MS, Parker MH, Scimè A, Parks R, Rudnicki MA (2004) Rb is required for progression through myogenic differentiation but not maintenance of terminal differentiation. View
22. Ferri P, Barbieri E, Burattini S, Guescini M, D'Emilio A, et al. (2009) Expression and subcellular localization of myogenic regulatory factors during the differentiation of skeletal muscle C2C12 myoblasts. View
23. Chan CY, Masui O, Krakovska O, Belozerov VE, Voisin S, et al. (2011) Identification of differentially regulated secretome components during skeletal myogenesis. View